In line with this, in vivo depletion of galectin-3 was shown to increase both the number of functional CD8+ T cells and the consequent expression of pro-inflammatory cytokines, thereby inducing tumor rejection in galectin-3-deficient mice (92, 94). This evidence concerns the gene LGALS3 and neoplasm.